Publications by authors named "Sadiya N Addo"

Claim this Profile
D
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia.
Vladimir Ivanov, Su-Peng Yeh, Jiri Mayer, Lalit Saini, Ali Unal, Sadiya N Addo

Future Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens.
Ning Sun, Sakina Petiwala, Charles Lu, Jessica E Hutti, Min Hu, Sadiya N Addo

CRISPR J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.
Clarissa G Jakob, Anup K Upadhyay, Pamela L Donner, Emily Nicholl, Sadiya N Addo

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.
Sonia G Das, Jignesh M Doshi, Defeng Tian, Sadiya N Addo, Balasubramanian Srinivasan

J Med Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.
David Hermanson, Sadiya N Addo, Anna A Bajer, Jonathan S Marchant, Sonia Goutam Kumar Das

Mol Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.
Liangyou Wang, Daniel T Sloper, Sadiya N Addo, Defeng Tian, Joel W Slaton

Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis